Omar Ishrak defended his company’s $42.9 billion plan to acquire Dublin-based Covidien in a so-called inversion deal, saying the medical device maker will be able to create more jobs in the United States.
By REUTERS, NY Times: Business
Tue, 08/19/2014 - 7:06pm
Omar Ishrak defended his company’s $42.9 billion plan to acquire Dublin-based Covidien in a so-called inversion deal, saying the medical device maker will be able to create more jobs in the United States.